{
    "RADCURE-1021": {
        "question": "Age: 63.6, Sex: Female, ECOG PS: ECOG 1, Smoking PY: 40, Smoking Status: Current, Ds Site: Esophagus, Subsite: Cervical esophagus, T: T2, N: N2, M : M0, Stage: none, Path: Squamous Cell Carcinoma, HPV: none, Tx Modality: RT alone, Chemo? : none, Dose: 70.0, Fx: 35, Local: Yes, Regional: none, Distant: none, 2nd Ca: Y, ContrastEnhanced: 1\nAnswer: ",
        "recruit-recruiter": "1. Radiation Oncologist - Your expertise is strictly limited to radiation therapy planning and dosing for head and neck squamous cell carcinoma, especially HPV-negative cases involving the cervical esophagus. - Hierarchy: Radiation Oncologist",
        "initial_assessment-radiation oncologist": "**Step 1: Initial Assessment of the CT Scan**\n\n- The CT scan is a sagittal view of the head and neck region.\n- Visible anatomical structures include the cervical vertebrae, the airway (pharynx and larynx), and soft tissues of the neck.\n- The vertebral bodies appear intact without obvious fractures or destructive lesions.\n- The airway lumen is patent but appears slightly narrowed at the level of the hypopharynx or cervical esophagus.\n- The masked region of interest (ROI) is highlighted in red and is located anterior to the cervical vertebrae, corresponding anatomically to the cervical esophagus.\n- The ROI shows a focal soft tissue mass or thickening, which is likely pathological.\n- No obvious distant metastases or gross lymphadenopathy are visible in this single slice.\n\n**Step 2: Mapping Bounding Boxes**\n\n- The bounding box coordinates are: [[254, 228, 128, 254, 262, 147], [254, 228, 128, 254, 262, 147]].\n- Both bounding boxes are identical, indicating a single region of interest.\n- These coordinates correspond to a volumetric region in the posterior neck, consistent with the location of the cervical esophagus and adjacent soft tissues.\n- This matches the masked ROI area seen on the scan, confirming the pathological region is the cervical esophageal lesion.\n\n**Step 3: Clinical Reasoning**\n\n- Patient is a 63.6-year-old female with squamous cell carcinoma of the cervical esophagus.\n- ECOG performance status is 1, indicating slight symptoms but ambulatory.\n- Heavy smoking history (40 pack-years) and current smoker, which worsens prognosis.\n- Tumor staging: T2 (tumor invades muscularis propria), N2 (multiple regional lymph nodes involved), M0 (no distant metastasis).\n- Treatment planned is radiation therapy alone, 70 Gy in 35 fractions, without chemotherapy.\n- Local control is targeted; no regional or distant treatment planned.\n- Presence of a second cancer is noted, which may complicate prognosis.\n- The lesion is visible as a soft tissue mass in the cervical esophagus on imaging.\n- HPV status is negative, which is associated with poorer prognosis compared to HPV-positive head and neck cancers.\n- Given the advanced nodal disease (N2) and smoking status, the risk of treatment failure and mortality is higher.\n- Radiation alone without chemotherapy may be suboptimal for N2 disease, potentially reducing survival chances.\n\n**Step 4: Integrated Conclusion**\n\n- The CT scan shows a cervical esophageal squamous cell carcinoma with a focal mass in the cervical esophagus.\n- The bounding box confirms the lesion location and extent.\n- Clinical factors (T2N2M0, smoking, HPV-negative, no chemotherapy) suggest a moderate to poor prognosis.\n- Radiation therapy alone at 70 Gy is standard but may be less effective without concurrent chemotherapy in N2 disease.\n- The presence of a second cancer further complicates survival.\n- Overall, the patient has a significant risk of mortality despite treatment.\n\n('Answer:Dead',)",
        "Round 1-role-comment": "radiation oncologist:dead",
        "Round 1-num_agents": 1,
        "Round 2-Turn 1-discuss-participate-radiation oncologist": "No",
        "Round 2-Turn 1-ask_gap-radiation oncologist": "Yes. \n\nType of expert needed: Medical oncologist and Head and Neck surgeon.\n\nReason: The patient's management involves complex decision-making beyond radiation therapy planning, including the role of chemotherapy (given N2 nodal disease and HPV-negative status) and potential surgical options. A medical oncologist can provide expertise on systemic therapy and combined modality treatment, while a head and neck surgeon can assess operability and surgical management, especially considering the presence of a second cancer and overall prognosis. These perspectives are essential for comprehensive multidisciplinary care and are not covered by the current radiation oncologist expertise.",
        "Round 2-Turn 1-gap_identified-assistant": "- Medical oncologist: To provide expertise on systemic therapy and combined modality treatment, especially considering N2 nodal disease and HPV-negative status.  \n- Head and neck surgeon: To assess operability and surgical management, particularly given the presence of a second cancer and overall prognosis.",
        "Round 2-Turn 1-gap_recruit-recruiter": "1. Medical Oncologist - Your expertise is strictly limited to systemic therapy decisions, including chemotherapy and immunotherapy in head and neck cancers, with a focus on HPV-negative squamous cell carcinoma and nodal disease management. - Hierarchy: Medical Oncologist == Radiation Oncologist  \n2. Head and Neck Surgeon - Your expertise is strictly limited to surgical evaluation and management of cervical esophageal squamous cell carcinoma, including assessment of operability and management of secondary cancers. - Hierarchy: Head and Neck Surgeon == Radiation Oncologist",
        "Round 2-Turn 1-gap_recruited_assessment-medical oncologist": "**Step 1: Initial Assessment of the CT Scan**\n\n- The CT scan is a sagittal view of the head and neck region, including upper thoracic structures.\n- Visible anatomical structures include the cervical vertebrae, the airway (pharynx and larynx), esophagus, and surrounding soft tissues.\n- The vertebral bodies appear intact without fractures or destructive lesions.\n- The airway lumen is patent without obvious obstruction.\n- The masked region of interest (ROI) is highlighted in red and is located anterior to the cervical vertebrae, consistent with the cervical esophagus.\n- The ROI shows a focal soft tissue mass or thickening, suggestive of a pathological lesion.\n- No obvious distant metastases or gross lymphadenopathy are visible in this single slice.\n\n**Step 2: Mapping Bounding Boxes**\n\n- The bounding box coordinates are: [[254, 228, 128, 254, 262, 147], [254, 228, 128, 254, 262, 147]].\n- Both bounding boxes are identical, indicating a single volumetric region of interest.\n- These coordinates correspond to a region in the posterior neck, anatomically consistent with the cervical esophagus and adjacent soft tissues.\n- This matches the location of the masked ROI on the scan, confirming the lesion is in the cervical esophagus.\n\n**Step 3: Clinical Reasoning**\n\n- Patient is a 63.6-year-old female with squamous cell carcinoma of the cervical esophagus.\n- ECOG performance status is 1, indicating she is ambulatory with some symptoms.\n- Heavy smoking history (40 pack-years) and current smoker, which negatively impacts prognosis.\n- Tumor staging: T2 (tumor invades muscularis propria), N2 (multiple regional lymph nodes involved), M0 (no distant metastasis).\n- Treatment planned is radiation therapy alone (70 Gy in 35 fractions) without chemotherapy.\n- No regional or distant treatment planned beyond local radiation.\n- Presence of a second cancer is noted, which may complicate prognosis.\n- HPV status is negative, associated with poorer prognosis compared to HPV-positive head and neck cancers.\n- Advanced nodal disease (N2) and smoking status increase risk of treatment failure and mortality.\n- Radiation alone without chemotherapy is generally suboptimal for N2 disease, potentially reducing survival chances.\n\n**Step 4: Integrated Conclusion**\n\n- The CT scan shows a cervical esophageal squamous cell carcinoma with a focal soft tissue mass in the cervical esophagus.\n- The bounding box confirms the lesion location and extent.\n- Clinical factors (T2N2M0, smoking, HPV-negative, no chemotherapy) suggest a moderate to poor prognosis.\n- Radiation therapy alone at 70 Gy is standard but may be less effective without concurrent chemotherapy in N2 disease.\n- The presence of a second cancer further complicates survival.\n- Overall, the patient has a significant risk of mortality despite treatment.\n\n('Answer:Dead',)",
        "Round 2-Turn 1-gap_recruited_assessment-head and neck surgeon": "**Step 1: Initial Assessment of the CT Scan**\n\n- The CT scan is a sagittal view of the head and neck region, extending into the upper thorax.\n- Anatomical structures visible include the cervical vertebrae, the airway (pharynx and larynx), the cervical esophagus, and surrounding soft tissues.\n- The vertebral bodies appear intact without evidence of destructive lesions or fractures.\n- The airway lumen is patent, with no obvious obstruction or extrinsic compression.\n- The masked region of interest (ROI), highlighted in red, is located anterior to the cervical vertebrae, consistent with the anatomical location of the cervical esophagus.\n- The ROI shows a focal soft tissue thickening or mass, which is likely pathological.\n- No obvious distant metastases or gross lymphadenopathy are visible in this single sagittal slice.\n\n**Step 2: Mapping Bounding Boxes**\n\n- The bounding box coordinates are: [[254, 228, 128, 254, 262, 147], [254, 228, 128, 254, 262, 147]].\n- Both bounding boxes are identical, indicating a single volumetric region of interest.\n- These coordinates correspond to a region in the posterior neck, anatomically consistent with the cervical esophagus and adjacent soft tissues.\n- This matches the location of the masked ROI, confirming the pathological lesion is within the cervical esophagus.\n\n**Step 3: Clinical Reasoning**\n\n- Patient is a 63.6-year-old female diagnosed with squamous cell carcinoma of the cervical esophagus.\n- ECOG performance status is 1, indicating the patient is ambulatory but symptomatic.\n- Significant smoking history (40 pack-years) and current smoking status, which negatively impacts prognosis.\n- Tumor staging: T2 (tumor invades muscularis propria), N2 (multiple regional lymph nodes involved), M0 (no distant metastasis).\n- Treatment planned is radiation therapy alone (70 Gy in 35 fractions) without chemotherapy.\n- No regional or distant treatment planned beyond local radiation.\n- Presence of a second primary cancer is noted, which may complicate overall prognosis.\n- HPV status is negative, which is associated with poorer outcomes in head and neck squamous cell carcinomas.\n- Advanced nodal disease (N2) and lack of chemotherapy may reduce treatment efficacy and survival.\n- Radiation alone in N2 disease is generally suboptimal; concurrent chemoradiation is preferred for better local control and survival.\n- The lesion is visible as a soft tissue mass in the cervical esophagus on imaging, consistent with clinical staging.\n\n**Step 4: Integrated Conclusion**\n\n- The CT scan confirms a cervical esophageal squamous cell carcinoma with a focal mass in the cervical esophagus.\n- The bounding box coordinates correspond to the lesion location and extent.\n- Clinical factors (T2N2M0, heavy smoking, HPV-negative, no chemotherapy) suggest a moderate to poor prognosis.\n- Radiation therapy alone at 70 Gy is standard but may be less effective without concurrent chemotherapy in N2 disease.\n- The presence of a second cancer further worsens prognosis.\n- Overall, the patient has a significant risk of mortality despite treatment.\n\n('Answer:Dead',)",
        "Round 2-Turn 1-Round 2-Turn 1-gap_recruited_discuss-participate-medical oncologist": "No",
        "Round 2-Turn 1-Round 2-Turn 1-gap_recruited_discuss-participate-head and neck surgeon": "No",
        "Round 2-role-comment": "radiation oncologist:dead|medical oncologist:dead|head and neck surgeon:dead",
        "Round 2-num_agents": 3,
        "num_cooperations-panel": 0,
        "decision-Moderator": "('Answer: Dead',)"
    }
}